Read More Pharma Industry News HUTCHMED to sell non-core JV for $608m to focus on oncology HUTCHMED (China) Limited has taken a bold step in streamlining its operations by divesting its 45% equity interest… byPallavi MadhirajuJanuary 5, 2025